Feb. 9, 2018
According to a Nufarm press release, the company’s program of work to integrate the portfolio into its European product suite is well advanced. In the first full year of Nufarm ownership (FY2019), the portfolio is expected to generate net sales of approximately $30 million an d contribute EBITDA of approximately $15 million. In the 2018 financial year, Nufarm anticipates an underlying EBITDA contribution from the newly acquired product portfolio of approximately $5 million.
Currently, Nufarm’s acquisition of the Century European product portfolio from Adama and Sygenta is progressing through the European Commission approval process. This process is ongoing, with acquisition completion anticipated in Q1 2018.